Paper41596328
Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line.
Samaszko-Fiertek J and 2 others. Int J Mol Sci, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line. Papers, record 41596328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596328
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Breast Neoplasms | Major topic |
| Coordination Complexes | Major topic |
| Humans | |
| Schiff Bases | |
| Female | |
| MCF-7 Cells | |
| Ligands |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DS/531-T100-D501-25 | University of Gdańsk | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36823294 | Novel Bromo and methoxy substituted Schiff base complexes of Mn(II), Fe(III), and Cr(III) for anticancer, antimicrobial, docking, and ADMET studies. | Sci Rep | 2023 | https://conductscience.org/library/papers/36823294 | PubMed |
| 2 | 35164049 | Different Schiff Bases-Structure, Importance and Classification. | Molecules | 2022 | https://conductscience.org/library/papers/35164049 | PubMed |
| 3 | 39502428 | Design and synthesis of a novel isoleucine-derived Schiff base ligand: Structural characterization, molecular docking, and in vitro biological activity evaluation. | Int J Health Sci (Qassim) | 2024 | https://conductscience.org/library/papers/39502428 | PubMed |
| 4 | 33634805 | Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells. | Dalton Trans | 2021 | https://conductscience.org/library/papers/33634805 | PubMed |
| 5 | 34139626 | A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/34139626 | PubMed |
| 6 | 37446670 | Synthesis, Crystal Structure, Antibacterial and In Vitro Anticancer Activity of Novel Macroacyclic Schiff Bases and Their Cu (II) Complexes Derived from S-Methyl and S-Benzyl Dithiocarbazate. | Molecules | 2023 | https://conductscience.org/library/papers/37446670 | PubMed |
| 7 | 37077261 | Synthesis, DNA binding and biological evaluation of benzimidazole Schiff base ligands and their metal(ii) complexes. | RSC Adv | 2023 | https://conductscience.org/library/papers/37077261 | PubMed |
| 8 | 24403503 | Understanding and improving platinum anticancer drugs--phenanthriplatin. | Anticancer Res | 2014 | https://conductscience.org/library/papers/24403503 | PubMed |
| 9 | 35456624 | Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456624 | PubMed |
| 10 | 36183642 | Synthesis, characterization, antioxidant potential, and cytotoxicity screening of new Cu(II) complexes with 4-(arylchalcogenyl)-1H-pyrazoles ligands. | J Inorg Biochem | 2022 | https://conductscience.org/library/papers/36183642 | PubMed |
| 11 | 39420621 | A novel copper(II) complex with a salicylidene carbohydrazide ligand that promotes oxidative stress and apoptosis in triple negative breast cancer cells. | Dalton Trans | 2024 | https://conductscience.org/library/papers/39420621 | PubMed |
| 12 | 37049692 | Catalytic, Theoretical, and Biological Investigations of Ternary Metal (II) Complexes Derived from L-Valine-Based Schiff Bases and Heterocyclic Bases. | Molecules | 2023 | https://conductscience.org/library/papers/37049692 | PubMed |
| 13 | 38922505 | Novel tetraaza macrocyclic Schiff base complexes of bivalent zinc: microwave-assisted green synthesis, spectroscopic characterization, density functional theory calculations, molecular docking studies, in vitro antimicrobial and anticancer activities. | Biometals | 2024 | https://conductscience.org/library/papers/38922505 | PubMed |
| 14 | 40054814 | Exploring the enzyme inhibitor potential and therapeutic applications of transition metal complexes of Methoxy-Schiff Base via triangular investigation. | Int J Biol Macromol | 2025 | https://conductscience.org/library/papers/40054814 | PubMed |
| 15 | 37959772 | Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes. | Molecules | 2023 | https://conductscience.org/library/papers/37959772 | PubMed |
| 16 | 38065049 | Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity. | J Inorg Biochem | 2024 | https://conductscience.org/library/papers/38065049 | PubMed |
| 17 | 37129705 | A novel water-soluble thiosemicarbazone Schiff base ligand and its complexes as potential anticancer agents and cellular fluorescence imaging. | J Biol Inorg Chem | 2023 | https://conductscience.org/library/papers/37129705 | PubMed |
| 18 | 30108933 | Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy. | Medchemcomm | 2018 | https://conductscience.org/library/papers/30108933 | PubMed |
| 19 | 24102434 | Advances in copper complexes as anticancer agents. | Chem Rev | 2014 | https://conductscience.org/library/papers/24102434 | PubMed |
| 20 | 38599004 | Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer. | J Inorg Biochem | 2024 | https://conductscience.org/library/papers/38599004 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42076047 | Palladium(II) Complexes with Chloro-Substituted Salicyl Schiff Bases: Exploring Multimodal Anticancer Mechanisms and Catalase Inhibition. | Molecules | 2026 | https://conductscience.org/library/papers/42076047 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41596328
GET https://conductscience.org/api/papers/v1/41596328/references?page=2